Ashis Mukhopadhyay

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial

Mary McCormack, D. Gallardo Rincón, Gemma Eminowicz et al. · Annals of Oncology · 2023 · 64 citations · Full text

Medicine, Oncology, Chemotherapy +13

Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia

Sunipa Majumdar, Bama Charan Mondal, Moloy Ghosh et al. · European Journal of Cancer Prevention · 2008 · 39 citations

Life Sciences, Genetics, Molecular Genetics +14

Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil

Sourav Kumar Nandi, Tanaya Roychowdhury, Samit Chattopadhyay et al. · Toxicology and Applied Pharmacology · 2022 · 39 citations

Medicine, Oncology, Pharmacology +16

Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy

Ashis Mukhopadhyay, S. Dasgupta, Ujjal Kanti Ray et al. · Irish Journal of Medical Science (1971 -) · 2014 · 33 citations

Medicine, Hematology, Oncology +13